Skip Navigation

Annals of Oncology 2009 20(Supplement 4):iv27-iv28; doi:10.1093/annonc/mdp119
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haie-Meder, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Haie-Meder, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

ESMO clinical recommendations

Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

C. Haie-Meder1, P. Morice2, M. Castiglione3 and On behalf of the ESMO Guidelines Working Group*

1 Department of Radiology
2 Surgery Service, Institut Gustave Roussy, Villejuif, France
3 Institute of Social and Preventive Medicine (ISPM), University of Geneva, Geneva, Switzerland

* Correspondence to: ESMO Guidelines Working Group, ESMO Head Office, Via L. Taddei 4, CH-6962 Viganello-Lugano, Switzerland E-mail: clinicalrecommendations@esmo.org

The first 10% of the full text of this article appears below.


   incidence
 
The crude incidence of cervical cancer in the European Union is 13.2/100 000 and the crude mortality rate is 5.9/100 000 women/year.


   diagnosis
 
Pathological diagnosis should be made according to the World Health Organization . . . [Full Text of this Article]


   staging
 

   treatment
 
FIGO stage IA1
FIGO stage IA2
FIGO stage IB1
FIGO stage IB2–IVA
FIGO stage IVB

   locoregional and metastatic recurrence
 

   follow-up
 

   note
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?